Curve Therapeutics
About:
Curve develops an innovative screening platform.
Website: https://www.curvetx.com/
Top Investors: Pfizer Venture Investments, Advent Life Sciences, British Patient Capital, Columbus Venture Partners, Epidarex Capital
Description:
Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve is deploying this platform to build a pipeline of novel cancer drugs.
40.5M GBP
Southampton, Southampton, United Kingdom
2019-01-01
info(AT)curvetx.com
11-50
2024-02-27
Private
© 2025 bioDAO.ai